Clinical Edge Journal Scan

Migraine: A significant risk factor for cardiovascular diseases


 

Key clinical point: Migraine or severe headache is a significant risk factor for cardiovascular diseases and significantly increases the risk for angina and stroke.

Major finding: Migraine or severe headache increased the overall risk for cardiovascular diseases (adjusted odds ratio [aOR] 2.77; P = .001), angina (aOR 2.27; P = .046), and stroke (aOR 3.80; P = .006), with the increased risk for cardiovascular diseases being the most prominent among participants with migraine who were women (aOR 6.02; P < .001), aged >60 years (aOR 2.69; P = .049), or had hypertension (aOR 3.57; P < .001) or hyperlipidemia (aOR 2.74; P = .003).

Study details: This cross-sectional study evaluated 5692 participants from the US National Health and Nutrition Examination Survey (NHANES), of which 1090 had migraine or severe headache.

Disclosures: This study was supported by grants from the National Natural Science Foundation of China and the Natural Science Foundation of Jiangsu Province. The authors declared no conflicts of interest.

Source: Wang K et al. Association between migraine and cardiovascular disease: A cross-sectional study. Front Cardiovasc Med. 2022;9:1044465 (Nov 24). Doi: 10.3389/fcvm.2022.1044465

Recommended Reading

High drug costs exclude most neurology patients from cutting-edge treatment
Migraine ICYMI
Evidence supporting atogepant as a promising treatment for migraine prevention
Migraine ICYMI
Alcohol as a trigger for migraine: What is the link?
Migraine ICYMI
Prior proton-pump inhibitor use ups migraine risk
Migraine ICYMI
Some patients with resistant chronic migraine may derive long-term benefits with erenumab
Migraine ICYMI
Migraine: Erenumab demonstrates superior efficacy over topiramate
Migraine ICYMI
Real world tolerability of onabotulinum toxin A in chronic migraine
Migraine ICYMI
Phytochemical and polyphenol rich diet reduces migraine severity
Migraine ICYMI
Erenumab serves as an effective and safe preventive treatment for migraine
Migraine ICYMI
How COVID-19 pandemic affected headache-related disability in young adults with migraine
Migraine ICYMI